Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need.Soligenix has two areas of focus: 1) a therapeutics segment dedicated to the development of products for orphan diseases and areas of unmet medical need such as cutaneous T-cell lymphoma, oral mucositis, pediatric Crohn's disease, acute radiation enteritis, and 2) a vaccines/biodefense segment to develop vaccines and therapeutics for military and civilian applications in the areas of ricin exposure, acute radiation syndrome, and emerging and antibiotic resistant infectious disease.

biotechnology oncology rare disease rare cancers oral mucositis Cutaneous T-Cell Lymphoma ricin toxin vaccine Pediatric Crohn’s disease Head and neck cancer Antibiotic resistant infectious disease Photodynamic therapy heat stable vaccines Melioidosis Hypericin Ebola Innate defense regulator Infectious disease Acute radiation enteritis Ricin exposure Acute radiation syndrome Orphan diseases bioterrorism BioTech/Drugs Commercial Physical Research Biotechnology